MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
$369,179
Unit: Dollar
Positive Cash Flow Breakdown
    • Proceeds from issuance of common...
    • Accounts payable - trade
    • Proceeds from issuance of common...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Repayment of financing liability
    • Accrued expenses
    • Payment of issuance costs relate...

Cash Flow
2026-06-30
2026-03-31
2025-12-31
Amortization of debt issuance costs and discounts
0 0 53,722
Accrued expenses
---453,445
Accrued interest - related party
-0 -
Change in fair value of derivative liabilities
0 0 6,312
Accrued interest
0 0 14,190
Gain on extinguishment of debt
0 0 326,345
Net loss
-1,205,312 -1,146,096 -5,167,569
Stock-based compensation
193,806 345,396 496,864
Shares issued in exchange for services
250,000 -250,000
Prepaid expenses and other current assets
--148,531
Prepaid expenses
-93,844 -88,282 -
Accounts payable - trade
260,275 -140,781 496,910
Accrued expenses
-42,777 256,901 -
Net cash used in operating activities
-450,164 -596,298 -4,777,892
Repayment of notes payable- related party
0 0 275,000
Proceeds from issuance of common stock and warrants in private placement
0 0 7,161,504
Repayment of financing liability
78,490 92,407 -
Proceeds from issuance of common stock pursuant to warrant exercises
669,106 --
Proceeds from issuance of common stock in private placement
260,000 652,000 -
Payment of issuance costs related to private placement
31,273 121,160 1,683,523
Net cash provided by financing activities
819,343 438,433 5,202,981
Net increase in cash and cash equivalents
369,179 -157,865 425,089
Cash and cash equivalents - beginning of period
301,309 459,174 34,085
Cash and cash equivalents - end of period
670,488 301,309 459,174
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Proceeds from issuance ofcommon stock pursuant...$669,106 Proceeds from issuance ofcommon stock in private...$260,000 Net cash provided byfinancing activities$819,343 Canceled cashflow$109,763 Net increase in cashand cash...$369,179 Canceled cashflow$450,164 Repayment of financingliability$78,490 Payment of issuancecosts related to...$31,273 Accounts payable - trade$260,275 Shares issued inexchange for services$250,000 Stock-based compensation$193,806 Prepaid expenses-$93,844 Net cash used inoperating activities-$450,164 Canceled cashflow$797,925 Net loss-$1,205,312 Accrued expenses-$42,777

ADAPTIN BIO, INC. (APTN)

ADAPTIN BIO, INC. (APTN)